Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. (CLDX) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0000744218 · CLDX · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0000744218 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Celldex Therapeutics, Inc. (NASDAQ: CLDX) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1986. As a Healthcare sector company with CIK 0000744218, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Celldex Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Celldex Therapeutics, Inc. 10-K was filed on 2026-02-25 for fiscal year ending 2026. Historical CLDX 10-K annual reports are available from 2007 through 2026.
Investors researching Celldex Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
CLDX SEC Filings · 8 questionsCelldex Therapeutics, Inc. (CLDX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Celldex Therapeutics, Inc.'s CIK is 0000744218.